About
Technology
Issues
FAQ
Links
Official Page
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.